北川孝一

キタガワコウイチ | Kitagawa Koichi

所属機関・部署：
職名：助教

研究分野 (1件)：腫瘍生物学

競争的資金等の研究課題 (1件)：

論文 (36件)：

植木秀登, 日向信之, 北川孝一, 岡村泰義, 原琢人, 寺川智章, 古川順也, 原田健一, 中野雄造, 白川利朗, et al. ペムブロリズマブを使用した進行性尿路上皮癌患者の予後予測因子についての免疫組織学的検討. 日本泌尿器科学会総会. 2021. 109回. PP26-02
Kayo Osawa, Katsumi Shigemura, Koichi Kitagawa, K Kuntaman, Ni Made Mertaniasih, Wahyu Setyarini, Dita Arizandy, Dadik Rahadjo, Ro Osawa, Toshiro Shirakawa, et al. Difference of Phenotype and Genotype Between Human and Environmental: Isolated Vibrio cholerae in Surabaya, Indonesia. Indian journal of microbiology. 2020. 60. 2. 230-238
Atsushi Uda, Katsumi Shigemura, Koichi Kitagawa, Kayo Osawa, Kenichiro Onuma, Shigeaki Inoue, Joji Kotani, Yonmin Yan, Yuzo Nakano, Tatsuya Nishioka, et al. How Does Antimicrobial Stewardship Affect Inappropriate Antibiotic Therapy in Urological Patients?. Antibiotics (Basel, Switzerland). 2020. 9. 2
Koichi Kitagawa, Katsumi Shigemura, Masashi Nomi, Nozomi Takami, Naoki Yamada, Masato Fujisawa. Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit. Spinal cord. 2020
Shigemura K, Kitagawa K, Chen KC, Sung SY, Fujisawa M. Effect of Preoperative Dutasteride on Holmium Laser Enucleation of the Prostate. Urologia internationalis. 2019. 1-5

MISC (1件)：

書籍 (1件)：

講演・口頭発表等 (24件)：

Oral cancer vaccine using recombinant Bifidobacterium expressing WT1 protein and anti-PD1 antibody induced WT1 specific immune responses via gut immune system in murine bladder cancer model
(CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE 2019)
Combination cancer immunotherapy of anti-PD-1 antibody with recombinant adenovirus vector carrying p53 gene for urogenital cancers
(CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE 2019)
Overexpression of SOCS3 mediated by adenovirus vector inhibited cell proliferation and increased chemosensitivity in triple-negative breast cancer cells in vitro and in vivo.
(第25回日本遺伝子細胞治療学会学術集会 2019)
WT1 oral cancer vaccine combined with anti-PD-1 antibody completely suppressed tumor growth in a murine bladder cancer model
(CIMT 2019 Annual Meeting 2019)
Possible molecular targeted therapy for invasive bladder cancer: Sonic hedgehog signaling inhibitor, cyclopamine
(34th Annual EAU Congress 2019)

学歴 (1件)：

学位 (2件)：

受賞 (1件)：

2017/06 - 日本ビフィズス菌センター/腸内細菌学会第21回腸内細菌学会最優秀発表賞 Wilms’ tumor 1タンパク発現ビフィズス菌を用いた経口癌ワクチンの抗腫瘍免疫誘導効果に関する検討

所属学会 (4件)：

日本分子生物学会 , 日本ワクチン学会 , American Society of Gene & Cell Therapy , 日本遺伝子細胞治療学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

北川 孝一